Vor Biopharma
(NASDAQ) VOR
Vor Biopharma Financials at a Glance
Market Cap
$762.02M
Revenue (TTM)
$0.00
Net Income (TTM)
$695.98M
EPS (TTM)
$-333.58
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$15.10
Volume
254,101.169
Open
$15.57
Price
$15.10
Volume
254,101.169
Open
$15.57
Previous Close
$15.60
Daily Range
$14.72 - $15.63
52-Week Range
$2.62 - $65.80
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$15.10
Volume
254,101.169
Open
$15.57
Previous Close
$15.60
Daily Range
$14.72 - $15.63
52-Week Range
$2.62 - $65.80
VOR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vor Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
76
CEO
Jean-Paul Kress, MD
Website
www.vorbio.comHeadquarters
Cambridge, MA 02140, US
VOR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-125%
Return on Capital
-85%
Return on Assets
-1%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$762.02M
Shares Outstanding
48.85M
Volume
254.10K
Short Interest
0.00%
Avg. Volume
992.28K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$371.64M
EBITDA
$368.75M
Operating Cash Flow
$142.71M
Capital Expenditure
$941.00K
Free Cash Flow
$143.65M
Cash & ST Invst.
$455.21M
Total Debt
$3.00M
Vor Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$23.00K
+97.3%
Gross Margin
0.00%
N/A
Market Cap
$762.02M
N/A
Market Cap/Employee
$4.79M
N/A
Employees
159
N/A
Net Income
$1.72B
+5709.7%
EBITDA
$35.94M
-20.4%
Quarterly Fundamentals
Net Cash
$452.21M
+652.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.72M
-90.2%
Short Term Debt
$280.00K
-93.4%
Return on Assets
-1.50%
N/A
Return on Invested Capital
-84.67%
N/A
Free Cash Flow
$23.11M
+4.2%
Operating Cash Flow
$22.80M
+5.2%